QI
REGN icon

Qualcomm Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Qualcomm Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$45K – 148
2015
Q1 		$45K Hold
100
– – 0.01% 143
2014
Q4 		$41K Hold
100
– – ﹤0.01% 164
2014
Q3 		$36K Hold
100
– – ﹤0.01% 165
2014
Q2 		$28K Sell
100
-10,200
-99% -$3.02M ﹤0.01% 189
2014
Q1 		$3.09M Hold
10,300
– – 0.16% 142
2013
Q4 		$2.83M Hold
10,300
– – 0.15% 146
2013
Q3 		$3.22M Buy
10,300
+1,700
+20% +$447K 0.15% 161
2013
Q2 		$1.93M Buy
+8,600
New +$2M 0.08% 185

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Qualcomm Inc's REGN Position: Q2 2015 in Review

Qualcomm Inc sold out of Regeneron Pharmaceuticals (REGN) in Q2 2015, closing a stake of 100 shares — an estimated $45K sold.

Qualcomm Inc first reported a position in REGN in Q2 2013 and held it in 8 quarters. The position peaked at $3.22M in Q3 2013. 541 funds tracked by Wall St. Rank hold REGN as of Q2 2015.

  • Qualcomm Inc reported no remaining Regeneron Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Qualcomm Inc sold 100 Regeneron Pharmaceuticals shares in Q2 2015, an estimated $45K.
  • Qualcomm Inc first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 8 quarters.
  • Qualcomm Inc's Regeneron Pharmaceuticals position peaked at $3.22M in Q3 2013.
  • 541 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2015.

Based on Qualcomm Inc's 13F filing for Q2 2015, filed 13 Aug 2015.